The store will not work correctly when cookies are disabled.
Methyl 4-(2-phenylimidazo[1,2-a]pyridin-6-yl)benzoate
ID: ALA4564832
PubChem CID: 155559723
Max Phase: Preclinical
Molecular Formula: C21H16N2O2
Molecular Weight: 328.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ccc(-c2ccc3nc(-c4ccccc4)cn3c2)cc1
Standard InChI: InChI=1S/C21H16N2O2/c1-25-21(24)17-9-7-15(8-10-17)18-11-12-20-22-19(14-23(20)13-18)16-5-3-2-4-6-16/h2-14H,1H3
Standard InChI Key: DOWBWDFYBJXHFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
16.4002 -8.4278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3990 -9.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1071 -9.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8168 -9.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8139 -8.4242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1053 -8.0189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5216 -9.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5215 -10.4719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2290 -10.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2251 -9.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9332 -9.6481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9402 -10.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7208 -10.7129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1963 -10.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7095 -9.3886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0121 -10.0378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4262 -10.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2426 -10.7370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6459 -10.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2269 -9.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4118 -9.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6924 -8.0193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6922 -7.2021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9848 -8.4281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2770 -8.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
22 23 2 0
22 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 328.37 | Molecular Weight (Monoisotopic): 328.1212 | AlogP: 4.45 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.36 | CX LogP: 4.44 | CX LogD: 4.44 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.52 | Np Likeness Score: -1.25 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |